Group One Trading’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Group One Trading’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-26,791	Closed	-$89K	–	6087
2019 Q4	$89K	Sell	26,791 -27,285	-50%	-$86.8K	﹤0.01%	3717
2019 Q3	$164K	Buy	+54,076	New	+$152K	﹤0.01%	3232
2018 Q3	–	Sell	-6,633	Closed	-$37.9K	–	5863
2018 Q2	$33K	Buy	+6,633	New	+$34.1K	﹤0.01%	4176
2018 Q1	–	Sell	-1,700	Closed	-$10K	–	5568
2017 Q4	$10K	Buy	+1,700	New	+$10.2K	﹤0.01%	4389
2017 Q3	–	Sell	-13,791	Closed	-$64K	–	5379
2017 Q2	$64K	Buy	13,791 +11,450	+489%	+$51.1K	﹤0.01%	3377
2017 Q1	$12K	Buy	+2,341	New	+$22.5K	﹤0.01%	4079

Group One Trading's FOMX Position: Q1 2020 in Review

Group One Trading sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 26,791 shares — an estimated $89K sold.

Group One Trading first reported a position in FOMX in Q1 2017 and held it in 6 quarters. The position peaked at $164K in Q3 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

Group One Trading reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Group One Trading sold 26,791 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $89K.
Group One Trading first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2017 and held it in 6 quarters.
Group One Trading's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $164K in Q3 2019.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Group One Trading's 13F filing for Q1 2020, filed 13 May 2020.